243 related articles for article (PubMed ID: 32057965)
1. Comparison of aqueous humor levels of PlGF and VEGF in proliferative diabetic retinopathy before and after intravitreal conbercept injection.
Zhang X; Wu J; Wu C; Bian AL; Geng S; Dai RP
Diabetes Res Clin Pract; 2020 Apr; 162():108083. PubMed ID: 32057965
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
[TBL] [Abstract][Full Text] [Related]
3. Proteomic changes of aqueous humor in proliferative diabetic retinopathy patients treated with different intravitreal anti-VEGF agents.
Chen H; Qiu B; Gao G; Chen Y; Min H; Wu Z
Exp Eye Res; 2022 Mar; 216():108942. PubMed ID: 35032522
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of angiogenic factors in aqueous humor associated with less intraoperative bleeding in PDR patients with NVG receiving conbercept: a randomized controlled trial.
Xu Q; Gong C; Qiao L; Feng R; Liu H; Liu Y; Yang L; Fan W; Guan L; Li J; Zhang Y; Li S
BMC Ophthalmol; 2022 May; 22(1):224. PubMed ID: 35585570
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection.
Zhou J; Liu Z; Chen M; Luo ZH; Li YQ; Qi GY; Liu T
Diabetes Ther; 2018 Dec; 9(6):2393-2398. PubMed ID: 30377995
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
Sawada O; Kawamura H; Kakinoki M; Sawada T; Ohji M
Arch Ophthalmol; 2007 Oct; 125(10):1363-6. PubMed ID: 17923544
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravitreal conbercept injection on VEGF-A and -B levels in the aqueous and vitreous humor of patients with proliferative diabetic retinopathy.
Zhang Y; Gao Z; Zhang X; Yuan Z; Ma T; Li G; Gao X
Exp Ther Med; 2021 Apr; 21(4):332. PubMed ID: 33732305
[TBL] [Abstract][Full Text] [Related]
8. What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.
Shi L; Yang J; Lin J
BMC Ophthalmol; 2019 Jun; 19(1):128. PubMed ID: 31185956
[TBL] [Abstract][Full Text] [Related]
9. Observation of total VEGF level in hyperglycemic mouse eyes after intravitreal injection of the novel anti-VEGF drug conbercept.
Du L; Peng H; Wu Q; Zhu M; Luo D; Ke X; Yang P; Lei B
Mol Vis; 2015; 21():185-93. PubMed ID: 25737631
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic and inflammatory biomarker levels in aqueous humor and vitreous of neovascular glaucoma and proliferative diabetic retinopathy.
Sun C; Zhang H; Jiang J; Li Y; Nie C; Gu J; Luo L; Wang Z
Int Ophthalmol; 2020 Feb; 40(2):467-475. PubMed ID: 31802372
[TBL] [Abstract][Full Text] [Related]
11. Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection.
Zhou M; Wang J; Wang W; Huang W; Ding X; Zhang X
PLoS One; 2016; 11(1):e0146993. PubMed ID: 26785251
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy.
Wu F; Phone A; Lamy R; Ma D; Laotaweerungsawat S; Chen Y; Zhao T; Ma W; Zhang F; Psaras C; Stewart JM
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):26. PubMed ID: 32084272
[TBL] [Abstract][Full Text] [Related]
13. Aqueous humour levels of vascular endothelial growth factor and erythropoietin in patients with diabetic macular oedema before and after intravitreal erythropoietin injection.
Lim JW; Han JR
Clin Exp Ophthalmol; 2011 Aug; 39(6):537-44. PubMed ID: 21819507
[TBL] [Abstract][Full Text] [Related]
14. Observation of optic disc neovascularization using OCT angiography in proliferative diabetic retinopathy after intravitreal conbercept injections.
Zhang X; Wu C; Zhou LJ; Dai RP
Sci Rep; 2018 Mar; 8(1):3972. PubMed ID: 29507304
[TBL] [Abstract][Full Text] [Related]
15. Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization.
Di Antonio L; Toto L; Mastropasqua A; Brescia L; Erroi E; Lamolinara A; Di Nicola M; Mastropasqua L
Sci Rep; 2018 Oct; 8(1):15631. PubMed ID: 30353107
[TBL] [Abstract][Full Text] [Related]
16. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
Matsumoto M; Suzuma K; Maki T; Kinoshita H; Tsuiki E; Fujikawa A; Kitaoka T
Am J Ophthalmol; 2012 May; 153(5):896-902.e1. PubMed ID: 22265145
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal conbercept improves outcome of proliferative diabetic retinopathy through inhibiting inflammation and oxidative stress.
Xia JP; Liu SQ; Wang S
Life Sci; 2021 Jan; 265():118795. PubMed ID: 33227274
[TBL] [Abstract][Full Text] [Related]
18. Aqueous Levels of Angiopoietin-like 4 and Semaphorin 3E Correlate with Nonperfusion Area and Macular Volume in Diabetic Retinopathy.
Kwon SH; Shin JP; Kim IT; Park DH
Ophthalmology; 2015 May; 122(5):968-75. PubMed ID: 25687026
[TBL] [Abstract][Full Text] [Related]
19. Monitoring intraocular proangiogenic and profibrotic cytokines within 7 days after adjunctive anti-vascular endothelial growth factor therapy for proliferative diabetic retinopathy.
Hu Z; Cao X; Chen L; Su Y; Ji J; Yuan S; Fransisca S; Mugisha A; Zou W; Xie P; Liu Q
Acta Ophthalmol; 2022 May; 100(3):e726-e736. PubMed ID: 34260829
[TBL] [Abstract][Full Text] [Related]
20. Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab.
Matsuyama K; Ogata N; Jo N; Shima C; Matsuoka M; Matsumura M
Jpn J Ophthalmol; 2009 May; 53(3):243-8. PubMed ID: 19484443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
